OTC · SRNE

Sorrento Therapeutics, Inc.

Healthcare · Biotechnology

$0.00

Up+$0.00 (+0.00%)

Updated Sep 18, 2026, 6:28 AM

SID Score

5.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 2.29M
P/E ratio: -0
Dividend yield: 0.00%
52-week range: $0.00 – $0.10
Volume: 134.89K
Avg. volume: 416.81K

Price performance

SRNE price history

1M range · 0 trading sessions · Daily adjusted prices

Data unavailable

The requested market data was not found.

Latest SRNE news

The latest Smart Investors Daily articles mentioning SRNE.

No results

No recent SID articles mention SRNE.

Latest SRNE news

The latest Smart Investors Daily articles mentioning SRNE.

Stock researchCompany · Overview

Company

Overview Forecast Earnings Dividend Financials

Market Activity

Options Insider Trades Short Interest Institutional Ownership Sentiment

Research & News

Analysis Competitors News SEC Filings SID Coverage

SRNE research

Overview

Company profile and research snapshot.

Company profile

SORRENTO THERAPEUTICS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus: Buy
Average target: $13.26
Implied upside: —
Analysts: 7

SRNE recent ratings
Date	Firm	Rating	Target
Nov 2, 2022	Cantor Fitzgerald	Overweight	—
Mar 25, 2022	HC Wainwright & Co.	Buy	—
Aug 9, 2021	HC Wainwright & Co.	Buy	—
Jan 21, 2021	Alliance Global Partners	Buy	—
Jul 31, 2020	HC Wainwright & Co.	Buy	—

Open full forecast

News briefing

No generated briefing is available yet.

defenseworld.net · Nov 19, 2025

Sorrento Therapeutics (NASDAQ:SRNE) versus NKGen Biotech (NYSE:NKGN) Head-To-Head Review

Institutional and Insider Ownership 0.0% of Sorrento Therapeutics shares are owned by institutional investors. Comparatively, 76.2% of NKGen Biotech shares are owned by institutional investors. 2.6% of Sorrento Therapeutics shares are owned by insiders. Comparatively, 10.4% of NKGen Biotech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By